Action 10. Promote the revision of national procurement plans to align with WHO recommended regimens and the Optimal Formulary, and support the provision of reliable forecasts and the consolidation of orders.

Action 22. Support the early adoption of priority formulations and diagnostics and take steps to facilitate their wider roll-out, including by developing introductory guidance, materials, and other tools for health facilities.

Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.

Action 28. Raising awareness in global fora about the unmet diagnostic and treatment needs of children with HIV.

Acton 29. Promote uptake by mobilizing their networks of hospitals and community structures to distribute paediatric medicines in hard to reach places and in situations of conflict and crisis.

Action 34: Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.

10. (individual commitment)The Global Network of People living with HIV (GNP+) committed to mobilize their networks, in particular women living with HIV, to increase demand generation, advocacy, and monitoring to increase access to treatment for children living with HIV.

Action 27

The Global Network of People Living with HIV (GNP+) launched a survey, The State of People Living with HIV at the end of 2017. This survey included questions on infants and childrens’ early diagnosis and optimal HIV treatment and care in their country as well as, information regarding stock outs of ARVs. Results of the survey are being analysed. GNP+ is planning to release the results at AIDS 2018.

 

Action 28

Results of the the State of People Living with HIV survey are being analyzed. GNP+ is planning to present the results at IAC2018.

Individual Commitment

The Global Network of People Living with HIV (GNP+) launched a survey, The State of People Living with HIV at the end of 2017. This survey included questions on infants and childrens’ early diagnoses and optimal HIV treatment and care in their country as well as, information regarding stock outs of ARVs. Results of the survey are being analysed. GNP+ is planning to release the results at AIDS 2018.

 

GNP+ launched a new webinar series to provide treatment updates to people living with HIV. The first webinar focused on access to dolutegravir (DTG) and viral resistance to first-line ARVs (2 March). Access to paediatric versions of DTG was discussed.  The DTG webinar recording is now available at www.gnpplus.net/civil-society-speaks-fighting-for-universal-access-to-dolutegravir-dtg/

51. Mobilize communities to reduce stigma and create demand for point of care diagnostics in order to improve early infant diagnosis.

Signed agreement in April with UNICEF on demand creation of POC EID diagnostics and to create a strategic framework and resource package to support countries to implement demand creation activities for POC EID in collaboration with communities and networks of PLHIV in the countries. GNP+ and UNICEF are currently working together to develop strategic framework as well as the resource pack for civil society engagement in POC EID. The initiative is intended to support scaling up POC EID in western and eastern Africa. GNP+ is planning information collection at the country level to support development of guidelines for civil society engagement and advocacy for POC EID technologies. These two strategic resources should be completed by the first quarter of 2020. Once finalized, plan to have several webinars to disseminate the documents to a broader audience.

56. Support treatment preparedness programs, ensure improvement of treatment awareness among caregivers of children of all ages and adolescents, and work jointly with other stakeholders on treatment literacy and demand creation for new pediatric formulations.

-